Kidney Stones Management Market is estimated to grow with a CAGR of 5.30% during the forecast period

Kidney Stones Management Market size was valued at USD 1.54 billion in 2020 and expected to expand to USD 2.57 billion at a compound annual growth rate (CAGR) of 5.30%.  Kidney stones, also known as urolithiasis or renal calculi, are hard deposits formed in the kidneys that are made up of salts and minerals. When the urine becomes concentrated, the minerals in the body crystallise, forming stones. The usage of certain supplements and drugs, as well as physical issues such as excess body weight, are the most common sources of such deposits. When the sediments obstruct the urinary tract, surgery is required to clear it. Percutaneous Nephrolithotomy, Uteroscopy, and Extracorporeal Shock Wave Lithotripsy are some of the procedures used to treat the stones (ESWL).

The report " Global Kidney Stones Management Market, By Type (Calcium Oxalate, Calcium Phosphate, Uric Acid, Struvite, and Cysteine), By Application (Extracorporeal Shock Wave Lithotripsy (ESWL), Ureteroscopy, and Percutaneous Nephrolithotomy), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030’’

Key Highlights:

  • In March 2020, Medi-Tate, an Israeli medical device firm, gained FDA approval for their iTind system, which is used to implant and remove nitinol devices during bladder neck reconstruction.

Analyst View:

The global kidney stone management market has developed steadily over the years and is projected to continue growing in the near future. This is due to an increase in the prevalence and recurrence of kidney stones over the world. Extracorporeal shock wave lithotripsy (ESWL), percutaneous nephrolithotomy, and ureteroscopy are some of the treatments available in the worldwide kidney stone management market. ESWL is the one that is now gaining the most traction in the industry. This is due to the fact that shock waves used to treat kidney stones are non-invasive. And, as more small and efficient devices become available, the treatment is expected to become more popular.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3440

Key Market Insights from the report:

The Global Kidney Stones Management Market size was valued at USD 1.54 billion in 2020 and expected to expand to USD 2.57 billion at a compound annual growth rate (CAGR) of 5.30%. The global kidney stones management market report segments the market on the basis of type, application, and region.

  • Based on Type, Global Kidney Stones Management Market is segmented into Calcium Oxalate, Calcium Phosphate, Uric Acid, Struvite, and Cysteine.
  • Based on Application, Global Kidney Stones Management Market is segmented into Extracorporeal Shock Wave Lithotripsy (ESWL), Ureteroscopy, and Percutaneous Nephrolithotomy.
  • By Region, the Global Kidney Stones Management Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of Global Kidney Stones Management Market:

The key players operating in the Global Kidney Stones Management Market includes Allengers Medical Systems Ltd., Boston Scientific Corporation, R. Bard Inc., Karl Storz GmbH & Co. KG, Cook Medical, Coloplast Group, DirexGroup, Dornier MedTech, Olympus Corporation and Richard Wolf GmbH

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Contact Us:

Sales

  1 860 531 2701

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

Comments

Post a Comment

Popular posts from this blog

Humanized Liver Mice Model Market is estimated to be US$ 133.72 billion by 2030 with a CAGR of 5.30% during the forecast period

Image
Humanized Liver Mice Model Market   accounted for US$ 78.64 million in 2020 and is estimated to be US$ 133.72 million by 2030 and is anticipated to register a CAGR of 5.30%.  A lot of studies are underway to create novel humanized liver mouse models. Initially, liver mice models were created by implanting human liver cells or hepatic cancer cells into basic immune-deficient mice. The results, however, were inconsistent and unreliable. As a result, immune-deficient mice were developed, which spontaneously destroy the mice liver, allowing human liver cells to proliferate and replace it, resulting in stable humanized liver mice models. For example, a number of research projects are looking into using PPARalfa and AFC8-based mice models to develop humanized liver mice models. The report "Global Humanized Liver Mice Model Market, By Model (uPA-SCID, FRG KO Mice, TK-NOG Mice  and Other Models) By Application (Pharmacokinetics Studies, In-vivo Liver Toxicity Testing, Drug Metabolism Stud
Read more

Bipolar Disorder Market is estimated to be US$ 6.7 billion by 2030 with a CAGR of 2.3% during the forecast period

Image
Bipolar Disorder Market   accounted for US$ 5.3 billion in 2020 and is estimated to be US$ 6.7 billion by 2030 and is anticipated to register a CAGR of 2.3%. Bipolar disorder known as manic depression is a mental illness that brings low moods and severe high moods, thinking, changes in sleep and have periods in which they feel overly happy and energized and other side feel very sad, hopeless and sluggish. Bipolar disorder can cause severe disruption to a person’s life which can be treated with appropriate treatment and support. The report "   Global Bipolar Disorder Market, By Disorder (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder), By Drug Class (Mood Stabilizer, Anticonvulsant, Antipsychotic Drugs, Antidepressant Drugs, and Antianxiety Drugs), By Mechanism of Action (Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Beta Blockers, and Benzodiazepines), By Region (North
Read more

Monkeypox Disease Diagnostics Market - The abrupt global expansion of the monkeypox virus has increased the demand for monkeypox diagnostics.

Image
  The virus that causes smallpox and the Monkeypox both belong to the same family of viruses. Two outbreaks of a disease resembling the pox in groups of monkeys used for study led to the discovery of monkeypox in 1958. However, it has been observed in various parts of the world except Africa, where it is primarily found. It results in symptoms that resemble the flu, such as fever, chills, and a rash that might take weeks to go away. Even though instances of monkeypox are uncommon, they are growing in Africa and other areas where they have never before occurred. The fact that monkeypox is a rare disease may lead a healthcare provider to first rule out other rash infections, such measles or chickenpox. A tissue sample from an open sore is the first step in the medical professional's diagnosis of monkeypox (lesion). After that, send to a lab for PCR (Polymerase Chain Reaction). Additionally, blood is drawn to test for antibodies or the monkeypox virus. Currently, there is no licens
Read more